This is unpublished

George E.

he, him, his
Physician & Research Faculty
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Associate Professor, Division of Medical Oncology, University of Washington
Sites of Practice
Seattle Cancer Care Alliance
UW Medical Center - Montlake

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.D., University of California, San Francisco 
  • Residency, University of Texas, Southwestern
  • Fellowship, UW 
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine

Clinical Expertise 

  • Hematopoietic stem cell transplant 
  • Hematologic malignancies 
  • Graft-vs.-host disease 
  • Autoimmune diseases





Research and/or clinical interests 

Dr. George Georges is a medical oncologist who treats patients with blood disorders such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndrome. His research seeks ways to reduce the toxicity of blood stem cell transplantation. Dr. Georges’ current research is focused on the use of blood stem cell transplantation to treat severe autoimmune diseases including aplastic anemia, systemic sclerosis, multiple sclerosis, and other neurologic autoimmune diseases such as chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, Stiff Person Syndrome, etc.  


Dr. Georges’ research interests lie in the following areas: 

  • Hematopoietic cell transplantation for severe autoimmune diseases: clinical trials evaluating autologous or allogeneic transplantation for diseases including systemic sclerosis, multiple sclerosis, aplastic anemia, and neurologic autoimmune diseases. 

  • Nonmyeloablative hematopoietic cell transplantation: regimens to reduce the toxicity of allogeneic transplantation, particularly in older patients or patients with medical comorbidities. 

  • Hematopoietic stem cell and T cell gene therapy: laboratory-based studies on hematopoietic stem cell expansion and genetic correction of underlying disease. 

  • Quality of life, late effects after hematopoietic cell transplantation.